Job posting has expired
Regional Director, MSLs - West
Blueprint Medicines | |
paid time off, 401(k)
| |
United States, Illinois, Chicago | |
Apr 29, 2025 | |
|
Preferred Locations: Seattle, Los Angeles, Dallas, Denver, Chicago How will your role help us transform hope into reality? The Regional Director, Medical Science Liaisons will be responsible for building, leading, and supporting the US MSL Hematology/Allergy field team for the West region. You will work collaboratively along with the National MSL Director and VP of Medical Affairs to establish long term vision, strategy, plans, objectives, and culture of the company's first field organization in the US and subsequently hire and manage a team of high performing MSLs. Reporting into the National Director of MSLs, you will develop strategic business plans in concert with Medical Affairs and appropriate cross-functional partners and will be accountable for the successful implementation of Medical Affairs Strategies at the field level. You will also be responsible for representing the Medical Affairs team, both internally and externally, as a clinical expert supporting potential product launches and ongoing pipeline development. What will you do?
What minimum qualifications do we require?
What additional qualifications will make you a stronger candidate?
Why Blueprint? At Blueprint Medicines, we achieve impactful results because of our global crew of compassionate innovators - the Blue Crew. Through authentic relationships and our collective entrepreneurial spirit and action, we are each empowered to take ownership and execute with strategic prioritization. We put trust in our people to break through norms and conventions using their individual strengths and insights, which drives our success. This is the place where the extraordinary becomes reality, and you could be part of it. Patients are waiting. Are you ready to make the leap? Compensation and Benefits The base salary hiring range for this position will be $225K-- $275K.* Actual base salary offered for this position will be based on a number of job-related factors, including, but not limited to: experience (including skills and competencies), education, training and internal equity. This position is also eligible for the following:
*Based on reasonable estimate for this job at the time of posting; ranges are reviewed periodically and subject to change. To apply, just scroll down and click on the "Apply Now" link, and do so by February 28th, 2025. Equal Employment Opportunity At Blueprint Medicines, we foster an environment of fair treatment and full participation for all of our employees as we navigate complex challenges in pursuing our mission to improve the lives of patients. We celebrate our unique differences and varied career and life experiences so that we can sustain our diverse culture and ensure everyone feels accepted. We are committed to non-discrimination, equal employment opportunity, as well as an inclusive recruitment process. We consider all qualified applicants based on merit and without regard to race, color, sex, gender identity, sexual orientation, age, religion, national origin, ancestry, ethnicity, disability, veteran status, genetic information, or any other characteristic protected under applicable federal or state law. We will make reasonable accommodations, absent undue hardship, for qualified individuals with known disabilities. If you are an individual with a disability in need of an accommodation with the application or recruiting process, please reach out toTotalRewards@blueprintmedicines.com. We are also an E-Verify Employer. For more information, please see our EEO Policy Statement, the E-Verify Participation Poster, the Right to Work Poster, and/or the EEO Know Your Rights Poster. Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines, including bringing our medicine to patients with systemic mastocytosis (SM) in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our impact by advancing a broad pipeline of programs ranging from early science to advanced clinical trials in mast cell diseases including SM and chronic urticaria, breast cancer and other solid tumors. #LI-Remote #LI-AQ1 | |
paid time off, 401(k)
Apr 29, 2025